The Phase 1 study of RLS-1496, the first human trial of a GPX4 (selective glutathione peroxidase 4) modulator, met its primary endpoint and also demonstrated a statistically significant relationship ...

Children with moderate to severe atopic dermatitis had improved skin barrier function with 16-week dupilumab treatment in both lesional and nonlesional skin, according to data published in Annals of ...

Almirall S.A. (ALM), a global biopharmaceutical company dedicated to medical dermatology, is presenting a broad range of clinical and real‑world data across its portfolio at the 2026 American Academy ...

A new study led by investigators at National Jewish Health and published in Annals of Allergy, Asthma & Immunology shows that ...

Almirall, a global biopharmaceutical company dedicated to medical dermatology, this weekend hosted the 17th edition of Skin ...

Repeated-measures modeling found no consistent links between active atopic dermatitis and BMI, blood pressure, lipid profiles ...

When you have atopic dermatitis, the most common form of eczema, your skin can be so sensitive that wearing a scratchy sweater or a garment with a tag or rough seam can lead to a flare-up. Atopic ...

For children with atopic dermatitis (AD), dupilumab treatment restores skin barrier function, according to a study published online Jan. 26 in the Annals of All ...

Atopic dermatitis, the most common form of eczema, affects millions of Americans with its hallmark symptoms of dry, itchy, and inflamed skin. While this chronic condition can impact individuals across ...

New research links atopic dermatitis to S1P signalling pathways driving inflammation. Learn how this could shape future ...

Credit: Getty Images. Clinical phenotypes of atopic dermatitis can vary greatly based on skin color and can make atopic dermatitis difficult to diagnose. Recognizing the clinical diversity of ...

Researchers found that dupilumab improved skin barrier integrity and reduced inflammation in children with atopic dermatitis.